Recent discussions on X about NVIDIA (NVDA) focus on the potential resumption of H20 chip sales to China, seen as a positive catalyst to alleviate financial pressures and reignite demand. Analyst upgrades and raised price targets reflect optimism about NVIDIA’s strategic position. Congressional trading shows active involvement from members, with notable trades by representatives and senators. Insider trading activity reveals significant sales by NVIDIA insiders, with no recent purchases. Hedge fund activity shows institutional investors making substantial moves in their portfolios, with notable additions and reductions in NVIDIA stock. Analyst ratings for NVIDIA have been mostly positive, with multiple firms issuing buy ratings. Price targets for NVIDIA have been set by various analysts, with a median target of $190.0. Overall, the news surrounding NVIDIA indicates a mix of positive sentiment and active trading activity among different stakeholders in the market.

Read more at Nasdaq: NVIDIA (NVDA) Opinions on Resumed Chip Sales to China